152 related articles for article (PubMed ID: 35882674)
1. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M
AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674
[TBL] [Abstract][Full Text] [Related]
2. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
[TBL] [Abstract][Full Text] [Related]
3. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.
Okamoto N; Higashino M; Yamamoto H; Sugano K
Pharm Res; 2024 May; 41(5):959-966. PubMed ID: 38653942
[TBL] [Abstract][Full Text] [Related]
4. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.
Sakamoto A; Sugano K
Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285
[TBL] [Abstract][Full Text] [Related]
5. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.
Tsume Y; Langguth P; Garcia-Arieta A; Amidon GL
Biopharm Drug Dispos; 2012 Oct; 33(7):366-77. PubMed ID: 22815122
[TBL] [Abstract][Full Text] [Related]
6. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer.
Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R
Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131
[TBL] [Abstract][Full Text] [Related]
7. Solubility vs Dissolution in Physiological Bicarbonate Buffer.
Claussen F; Al-Gousous J; Salehi N; Garcia MA; Amidon GL; Langguth P
Pharm Res; 2024 May; 41(5):937-945. PubMed ID: 38698196
[TBL] [Abstract][Full Text] [Related]
8. Is bicarbonate buffer suitable as a dissolution medium?
Boni JE; Brickl RS; Dressman J
J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE
Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520
[TBL] [Abstract][Full Text] [Related]
10. The effect of buffer species on biorelevant dissolution and precipitation assays - Comparison of phosphate and bicarbonate buffer.
Krollik K; Lehmann A; Wagner C; Kaidas J; Kubas H; Weitschies W
Eur J Pharm Biopharm; 2022 Feb; 171():90-101. PubMed ID: 34592364
[TBL] [Abstract][Full Text] [Related]
11. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
Shibata H; Yoshida H; Izutsu K; Goda Y
J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
[TBL] [Abstract][Full Text] [Related]
12. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
Liu F; Shokrollahi H
Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
[TBL] [Abstract][Full Text] [Related]
13. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
14. Dissolution Methods to Increasing Discriminatory Power of In Vitro Dissolution Testing for Ibuprofen Free Acid and Its Salts.
Cristofoletti R; Dressman JB
J Pharm Sci; 2017 Jan; 106(1):92-99. PubMed ID: 27397434
[TBL] [Abstract][Full Text] [Related]
15. Development of bicarbonate buffer flow-through cell dissolution test and its application in prediction of in vivo performance of colon targeting tablets.
Ikuta S; Nakagawa H; Kai T; Sugano K
Eur J Pharm Sci; 2023 Jan; 180():106326. PubMed ID: 36347443
[TBL] [Abstract][Full Text] [Related]
16. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.
Sheng JJ; McNamara DP; Amidon GL
Mol Pharm; 2009; 6(1):29-39. PubMed ID: 19183104
[TBL] [Abstract][Full Text] [Related]
17. Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen.
Cámara-Martinez I; Blechar JA; Ruiz-Picazo A; Garcia-Arieta A; Calandria C; Merino-Sanjuan V; Langguth P; Gonzalez-Alvarez M; Bermejo M; Al-Gousous J; Gonzalez-Alvarez I
Int J Pharm; 2022 Feb; 614():121415. PubMed ID: 34973409
[TBL] [Abstract][Full Text] [Related]
18. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.
Merchant HA; Goyanes A; Parashar N; Basit AW
Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730
[TBL] [Abstract][Full Text] [Related]
19. Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing.
Sudaki H; Fujimoto K; Wada K; Sugano K
Drug Metab Pharmacokinet; 2023 Aug; 51():100519. PubMed ID: 37393739
[TBL] [Abstract][Full Text] [Related]
20. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.
Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
